1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Dermatitis, Irritant: new trials by email Literature Review of Dermatitis, Irritant trials Research Report on Dermatitis, Irritant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects Butenafine HCl 1% (BAY1896425) - Dermatitis, Phototoxic | Phase 3 | Completed | Bayer | 32 | 2013-06-24 | 2020-11-13 |
Dermatitis (1) · Dermatitis, Contact (1) · Photosensitivity Disorders (1) · Skin Diseases (1) · Skin Diseases, Eczematous (1) · Skin and Connective Tissue Diseases (1)
butenafine (1)
Bayer (1)
United States (1)